Study Links Paxil to Breast Cancer Patient Deaths

Bad news for GSK and generics manufacturers of Paxil came this week in the form of
a study published in the Journal of the American Medical Association (JAMA). The study, which was conducted by researchers at the University of California, San Francisco, found that women who took Paxil for depression were more likely to die of breast cancer than women who took a placebo.

The study, which was